Extracranial implantable devices, systems and methods for the treatment of neuropsychiatric disorders

US9511223B2 · kind B2 · utility

Assignees

• The Regents of the University of California · US
• NEUROSIGMA, INC. · US

Inventors

• Christopher M. DeGiorgio · Valencia, US
• Ian A. Cook · Los Angeles, US
• Leon Ekchian · Glendale, US

Key dates

• Filing date: Feb 11, 2015
• Grant date: Dec 6, 2016
• Expiry date: Feb 11, 2035

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61N1/36175
• WIPO field: Medical technology
• WIPO sector: Instruments

Abstract

The present disclosure relates to methods, devices, and systems used for the treatment of mood, anxiety, cognitive, and behavioral disorders (collectively, neuropsychiatric disorders) via stimulation of the superficial elements of the trigeminal nerve (“TNS”). More specifically, minimally invasive systems, devices and methods of stimulation of the superficial branches of the trigeminal nerve located extracranially in the face, namely the supraorbital, supratrochlear, infraorbital, auriculotemporal, zygomaticotemporal, zygomaticoorbital, zygomaticofacial, nasal and mentalis nerves (also referred to collectively as the superficial trigeminal nerve) are disclosed herein.